Sexually Transmitted Diseases (STD) Prevention and Control Grants — CFDA 93.977

STD prevention-grant obligations at $603.1M

USAspending.gov records $603,087,854.92 in obligations under CFDA 93.977. Sixty-two awards produce that stock. A simple average is about $9.73 million per award. That average is a quotient of two packet totals, not a typical health-department invoice and not a cost per test.

The assistance-listing title is SEXUALLY TRANSMITTED DISEASES (STD) PREVENTION AND CONTROL GRANTS. CFDA 93.977 is the identifier. Other CDC HIV, viral-hepatitis, or immunization listings tagged under different CFDA numbers are not mixed into the $603.1M. Combining those codes would invent a combined STI-prevention total this packet does not contain.

50 recipients on 62 award rows

Fifty recipients share 62 awards, or about 1.24 award records per recipient on average. Splitting $603,087,854.92 evenly would assign about $12.06 million per recipient. That density is a health-department cooperative fingerprint: almost one assistance row per named organization, each carrying a sizable dollar stock. The packet does not list the 50. Recipient count is the organizational headcount on the federal extract, not a census of clinics or people tested.

Thirty-four states in the geographic count is a partial map. Prevention dollars follow cooperative geography as coded, not a 50-state equal share. Place-of-performance amounts are on the program table.

Award rows are not a case census

Among HHS prevention listings, 93.977 is a low-row cooperative file: 62 awards against 50 recipients. Award count is a weak proxy for “number of STD programs” and a worse proxy for diagnoses. Recipients (50) tell you how many named organizations sit on the extract; awards (62) tell you how many assistance rows were stored.

The packet does not report tests, cases, or partner services. Citing 62 as diagnoses would be a unit error. Keep the units straight: dollars, awards, recipients, states. Sixty-two awards at about $9.73 million each is health-department cooperative architecture, not a case registry.

Obligations versus STD-prevention outlays

The $603.1M is an obligation total from USAspending.gov. Outlays — cash paid against STD Prevention and Control Grants — are not in the packet. A cooperative file can show a large obligation stock while reimbursements follow a later calendar. Deobligations and upward adjustments both move the total. A remaining-balance question is an outlay question this extract does not answer.

Use CFDA 93.977 to size this STD prevention and control listing in the assistance file. Do not use it as an HIV, immunization, or notifiable-disease dashboard. Those series live elsewhere. This page reports the obligation book tagged 93.977.

What the 93.977 tables omit

The program hub lists award-backed obligations from USAspending.gov. It is not a case registry, not a clinic directory, and not a testing log. Series that never appear as assistance awards will not show up in the $603,087,854.92. That omission is definitional rather than a gap in the 62 award rows.

Place-of-performance on 34 states is a coding field. Read the program page before treating those cells as a national STD total. Recipient dollars, if shown on the hub, are still obligation amounts, not cash already paid to health departments.

STD prevention grants’ 34-state map and 50-recipient headcount together describe a compact health-department cooperative, not a clinic-encounter ledger. A researcher comparing 93.977 with HIV or immunization codes should keep CFDA numbers separate. The $603.1M stock is the USAspending obligation book for this listing only.

Where the 93.977 table lives

The program page overlays these four facts. The all-programs index ranks 93.977 among other assistance listings. Agency pages show awarding-agency rollups that may include this CFDA among other HHS listings. For 93.977 only, start on the program page.

CFDA 93.977’s 62 awards spread $603,087,854.92 across 50 recipients and 34 states. Quote award count as a record count, recipient count as the organizational headcount, and dollars as obligations from USAspending.gov. About 1.24 award records per recipient is the density story on this listing. Outlays remain a separate column. Source: USAspending.gov assistance awards.

Tests, cases, and partner services live in other CDC series. Those rows are outside $603,087,854.92 unless they share CFDA 93.977. Quote 62 as assistance records, 50 as organizational payees, and 34 as the geographic count.

Questions

How much is obligated for STD prevention and control grants?

USAspending.gov records $603.1M in obligations for CFDA 93.977. SpendingVault indexes 62 awards, 50 recipients, and 34 states. The figure is an obligation sum from assistance awards, not an outlay and not a case count. CFDA 93.977’s $603,087,854.92 is the USAspending obligation stock.

How many awards does CFDA 93.977 carry?

The listing shows 62 awards against 50 recipients, or about 1.24 award records per recipient. A simple average is about $9.73 million per award. Award count is not a count of tests or diagnoses. Recipient dollars are on the program page.

How many organizations receive 93.977 awards?

The extract lists 50 recipients. Those are organizational recipients on assistance awards tagged 93.977, not a census of clinics or people tested. Geographic coding covers 34 states. The packet does not name the 50 or publish case counts. Keep dollars, awards, recipients, and geography as separate units on the USAspending extract.

Is $603.1M already paid for STD prevention?

Not necessarily. Obligations are commitments. Outlays are payments. CFDA 93.977’s indexed total is the obligation stock from USAspending.gov. This page does not report cash drawn, remaining balances, or tests delivered. The $603,087,854.92 on 62 awards is the obligation figure. Keep dollars, awards, recipients, and geography as separate units on the USAspending extract.